Cathepsin B regulates non‐canonical NLRP 3 inflammasome pathway by modulating activation of caspase‐11 in Kupffer cells
Year: 2018
Type: article
Abstract: Objectives The non‐canonical inflammasome pathway was described which engages caspase‐11 to mediate pyroptosis and the subsequent release of IL ‐1α, IL ‐1β and IL ‐18 in TLR 4‐independent way. Cathepsin B is capable of activating caspase‐11 under cell‐free conditions which may regulate non‐canonical NLRP 3 inflammasome pathway. In this study, we aimed to further investigate cathepsin B as potential activators of proinflammatory caspases which may be released upon proinflammatory stimuli and regulate non‐canonical NLRP 3 inflammasome pathway by modulating the activity of caspase‐11. Methods Pharmacological and gene‐silencing approaches were used to evaluate the impact of cathepsin B on regulating non‐canonical NLRP 3 inflammasome pathway in wild‐type and TLR 4 –/– Kupffer cells. A sepsis model was also created to investigate the effect of cathepsin B on survival. Meanwhile, cathepsin B activity and the expression level of caspase‐4 were detected in human peripheral blood mononuclear cells ( PBMC ) which were separated from patients suffered from SIRS or sepsis and healthy volunteers. Results LPS stimulation caused cathepsin B activity and caspase‐11 expression increase in TLR 4 –/– mice. Cathepsin B activity inhibition reduced the activation of caspase‐11 and inflammasome and benefited survival in TLR 4 –/– mice. Upregulation of cathepsin B activity and caspase‐4 activation was found in PBMC of patients with SIRS or sepsis. Conclusion Our results suggest a critical role for cathepsin B as activators of proinflammatory caspases‐11 and the regulatory effect in LPS ‐induced caspases‐11‐dependent necrosis.
Source: Cell Proliferation
DOI: 10.1111/cpr.12487
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2887802841
